Acceleron Pharma Reports First Quarter 2016 Financial and Operational Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. HUM
2. SPCX
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. ZETA
9. DAL
10. TMUS

Go back to Acceleron Pharma Reports First Quarter 2016 Financial and Operational Results

Acceleron Pharma (XLRN) Tops Q1 EPS by 40c

May 5, 2016 7:52 AM EDT

Acceleron Pharma (NASDAQ: XLRN) reported Q1 EPS of $0.14, $0.40 better than the analyst estimate of ($0.26). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $8.7 million.

Cash, cash equivalents and investments as of March 31, 2016 were $278.7 million. Net cash provided by operating activities in first quarter 2016 was $0.9 million. As of December 31, 2015 the Company had... More